Astrazeneca plc Common Stock

Astrazeneca plc (AZN) currently reports a common stock of $390M as of December 2025. That compares with $390M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Astrazeneca plc's common stock history and peer comparisons.

Astrazeneca plc's common stock was unchanged from $390M to $390M — essentially flat versus a year earlier (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Astrazeneca plc reported $390M in common stock as of December 2025. That compares with $390M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $390M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Astrazeneca plc, and consider following AZN for alerts when major investors trade the stock.

Astrazeneca plc is classified in the Healthcare sector. On common stock, it currently shows $390M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AZN with unrelated industries.